| This week's sponsor is Premier Research. | | | How Psoriasis Treatment Advanced, and What's Next
Thanks to new biologics, more than half of treated psoriasis patients achieve essentially clear skin. Our white paper examines how we got here, and what's next. Premier Research. It's what we do. Best. |
Today's Rundown Teva restructuring puts R&D programs on the chopping block Atlas-backed I-O specialist Kyn Thera comes out of stealth mode Allergy, inflammation player Allakos reels in $100M series B [Sponsored] How Real-World Evidence and Value-Based Contracts Can Help Payers and Manufacturers Find Common Ground in Rare Disease New investors, including Google, boost Relay in $63M round Bristol-Myers boosts I-O offering with new Ono drug deal After 2 share-crushing flops, Ampio claims phase 3 success Evotec in retinal disease drug research collaboration with academia Teva's stunning list of cuts targets 14K jobs, $3B in costs, and plants around the globe Featured Story | | | Thursday, December 14, 2017 Teva's restructuring plan will include the closure or divestiture of R&D facilities, as well as a "thorough review" of its R&D programs. |
|
|
| This week's sponsor is FierceBiotech. | | | |
Top Stories Thursday, December 14, 2017 The immuno-oncology sector has yet another player. Kyn Therapeutics just made its debut after almost two years of gestation at Atlas Venture with three immuno-metabolism platforms and $49 million in first-round funding. Wednesday, December 13, 2017 Five years after bagging a modest $30 million in series A financing, Allakos has picked up a hefty $100 million to propel its antibody treatments through the clinic. Monday, December 11, 2017 When payers and manufacturers brawl over pricing, patients with rare diseases can suffer. Is there any common ground? Both sides believe real-world evidence can help quantify the benefits of a medication, and value-based contracts can ensure patients reap the rewards. Thursday, December 14, 2017 Relay Therapeutics has bumped up its cash with a strong second funding round as it eyes clinical work on its next-generation cancer drug development. Thursday, December 14, 2017 Bristol-Myers Squibb has licensed a phase 1 immuno-oncology drug from Japan’s Ono in a $40 million upfront pact. Thursday, December 14, 2017 Ampio Pharmaceuticals has claimed success in a phase 3 osteoarthritis trial at the third attempt. But with the study using a new endpoint and a control arm pooled from multiple trials, the data received a muted response from investors. Thursday, December 14, 2017 CRO Evotec, in a new partnership with academia, will apply its leading induced pluripotent stem cell technology to identify novel drug candidates for retinal diseases. Thursday, December 14, 2017 Teva’s layoffs and cost cuts are here—and they're far larger and deeper than reports predicted. The company intends to ax 14,000 jobs, more than one-fourth of its worldwide workforce, while shutting down plants, R&D facilities, and offices around the globe. Resources Sponsored by: Seton Hall Don’t miss this educational program trusted by multi-national companies as part of their employee’s compliance training. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating in the Asia-Pacific region. Visit event page for session topics. Sponsored by: Reprints Desk SO CLOSE AND YET SO FAR. Is that how many documents seem to you? Getting what you want—when, where, and how you want it—can be a real pain. That’s why we created this concise guide to getting around the obstacles that stand between you and the information your organization needs. Download the whitepaper to learn more. Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Deloitte Sourcing research externally seems to be the preferred path for biopharma companies to strengthen their R&D pipeline. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Sponsored by: Veeva Systems Read Deloitte Consulting's whitepaper on the value of a holistic RIM capability, covering the potential cost savings and revenue gains from doing RIM right. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Sponsored by: Veeva Systems See the results from one of the largest, most in-depth surveys of clinical data management professionals on data management practices, performance, and challenges. Sponsored by: Veeva Systems Gain a complete, real-time view of quality and streamline operations. Incorporate partners into processes for critical oversight and 30% greater efficiency, and transform cross-functional processes like change control. Presented by: DSM Biomedical Discover DSM's Dyneema Purity® membrane, an effective and efficient material to construct stent grafts used in minimally invasive surgeries to treat both cardiovascular and peripheral arterial diseases. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. FierceBiotech Executive Breakfast: Get Good Science and the Money will Follow January 9, 2018 | San Francisco, CA BIO CEO & Investor Conference February 12-13, 2018 | New York, New York | 